ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has secured a $200,000 purchase order for RapiMed® from Global Pharma Hub for the Hong Kong market. ScripsAmerica's RapiMed® Pain Reliever and Fever Reducer for children will be supplied to a network of independent pharmacies operating in Hong Kong, which is home to a $988 Million pharmaceutical and OTC market expected to reach $1.5 Billion by 2019. Consumers in Hong Kong and China are driving the demand for safe and reliable American made OTC medications like RapiMed due to environmental hazards, counterfeit medications and quality control concerns across Asia, cites ScripsAmerica.

Bob Schneiderman, CEO of ScripsAmerica, said, "We are very proud and excited to announce our first international purchase order of RapiMed. This is a significant milestone for ScripsAmerica that is the result of our diligent marketing and business development efforts in Hong Kong and partnership with Global Pharma Hub."

"With Hong Kong's robust economic growth and high standard of living, its citizens have become increasingly conscious of their health and well-being and as a result, are fueling a rapidly growing demand for safe and effective OTC medications. As RapiMed gains market awareness, we expect to secure larger orders and gain greater market share."

"With our initial $200,000 purchase order for Hong Kong, recent licensing agreement to distribute RapiMed in Canada and being in the application process to distribute RapiMed in mainland China, 2014 is lining up to be a breakout year for ScripsAmerica's global market penetration, revenues and shareholder value," concluded Schneiderman. About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.

Safe Harbor Statement This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: 888-959-7095
         ir@sealpointconsulting.com
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more ScripsAmerica (CE) Charts.
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more ScripsAmerica (CE) Charts.